Recent News

• 04.03.2025 - RBC Inaugural Virtual Ophthalmology Conference
• 04.03.2025 - RBC Inaugural Virtual Ophthalmology Conference
• 04.01.2025 - Bill Maughan, Ph.D.
• 04.01.2025 - Bill Maughan, Ph.D.
• 03.19.2025 - REGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY
• 03.19.2025 - REGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY
• 03.17.2025 - UBS 2025 Virtual CNS Day
• 03.17.2025 - UBS 2025 Virtual CNS Day
• 03.13.2025 - Q4 2024 REGENXBIO Inc. Earnings Conference Call
• 03.13.2025 - Q4 2024 REGENXBIO Inc. Earnings Conference Call

Recent Filings

• 03.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 3 Initial statement of beneficial ownership of securities
• 03.13.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.13.2025 - POSASR Post-effective Amendment to an automatic shelf registration statement
• 03.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.13.2025 - POS AM Post-Effective amendments for registration statement
• 03.13.2025 - 8-K Current report
• 03.13.2025 - EX-99.1 EX-99.1